Cantor Fitzgerald’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,446
| Closed | -$67.5K | – | 420 |
|
|
2025
Q1 | $67.5K | Hold |
15,446
| – | – | ﹤0.01% | 219 |
|
|
2024
Q4 | $72.1K | Hold |
15,446
| – | – | ﹤0.01% | 186 |
|
|
2024
Q3 | $108K | Hold |
15,446
| – | – | ﹤0.01% | 126 |
|
|
2024
Q2 | $106K | Hold |
15,446
| – | – | 0.02% | 148 |
|
|
2024
Q1 | $218K | Sell |
15,446
-370
| -2% | -$5.23K | 0.05% | 135 |
|
|
2023
Q4 | $119K | Sell |
15,816
-190
| -1% | -$1.43K | 0.02% | 150 |
|
|
2023
Q3 | $240K | Sell |
16,006
-278
| -2% | -$4.17K | 0.01% | 397 |
|
|
2023
Q2 | $259K | Buy |
16,284
+2,000
| +14% | +$31.8K | 0.01% | 446 |
|
|
2023
Q1 | $102K | Buy |
14,284
+784
| +6% | +$5.62K | ﹤0.01% | 562 |
|
|
2022
Q4 | $78K | Buy |
13,500
+11,500
| +575% | +$66.4K | ﹤0.01% | 609 |
|
|
2022
Q3 | $19K | Buy |
+2,000
| New | +$19K | ﹤0.01% | 687 |
|